insights_auto
Outlook: 35.7% bullish·7.1% bearish
Go to analysischevron_right
AMGN34:BVMF
Amgen Inc. BDR
R$ 85.84
0.00%
(0.00) 1D
10-р сарын 26, 16:56:00 (GMT-3) · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMGN34...
Open
R$ 77.22
High
R$ 85.84
Low
R$ 77.22
Mkt. cap
240.38Т
Avg. vol.
391.00
Volume
415.00
52-wk high
R$ 85.84
52-wk low
R$ 47.76
Shares outstanding
540.63 сая
No. of employees
32 мян
Open
R$ 77.22
High
R$ 85.84
Low
R$ 77.22
Mkt. cap
240.38Т
Avg. vol.
391.00
Volume
415.00
52-wk high
R$ 85.84
52-wk low
R$ 47.76
Shares outstanding
540.63 сая
No. of employees
32 мян
News stories
From web sources and news partners
Investing.com Nigeria
·
4 цагийн өмнө
Amgen appoints former Yum! Brands CEO to board of directors By Investing.com
CNBC
·
9 цагийн өмнө
Committee stocks on the move: EQT Corporation, Amgen and Lockheed Martin
Yahoo Finance
·
16 цагийн өмнө
Jefferies Adjusts Price Target on Amgen to $428 From $410
JournalArta
·
1 өдрийн өмнө
Amgen’s Higher Yield Faces Gilead’s Lower Payout and Valuation
Profile
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
About Amgen Inc. BDR
CEORobert A. Bradway
Employees31.5 мян
Founded1980
HeadquartersТаузенд Өүкс, Калифорни, Америкийн Нэгдсэн Улс
Sector-
Websiteamgen.com